Dynavax Technologies Corp (NAS:DVAX)
$ 13 -0.03 (-0.23%) Market Cap: 1.71 Bil Enterprise Value: 1.17 Bil PE Ratio: 100.23 PB Ratio: 2.51 GF Score: 70/100

Q2 2019 Dynavax Technologies Corp Earnings Call Transcript

Aug 07, 2019 / 08:30PM GMT
Release Date Price: $2.99 (+3.82%)
Operator

Good day, ladies and gentlemen, and welcome to the Dynavax Technologies Second Quarter 2019 Conference Call. As a reminder, this conference call is being recorded.

I would now like to introduce your host for today's conference, Ms. Heather Rowe, Vice President of Investor Relations and Corporate Communications. You may go ahead.

Heather Rowe
Dynavax Technologies Corporation - VP of IR & Corporate Communications

Thank you, operator. Good afternoon, and welcome to the Dynavax Second Quarter 2019 Financial Results and Corporate Update Conference Call. With me today are Ryan Spencer, Co-President and Senior Vice President, Commercial; and Michael Ostrach, Chief Financial Officer.

Before we begin, I advise you that we will be making forward-looking statements today, including statements about HEPLISAV-B's commercial profile and expectations regarding HEPLISAV-B, including the amount and timing of revenue, rates of adoption and reorder, clinical and financial information and our abilities to successfully pursue strategic alternatives for our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot